Botanix

Botanix Pharmaceuticals is a pharmaceutical company focused on the treatment of skin diseases. Its mission is to improve the lives of patients suffering from acne, psoriasis, and atopic dermatitis by providing new treatment options for conditions that are currently underserved or treated with agents carrying significant side effect profiles. Botanix Pharmaceuticals is leveraging the untapped potential of synthetic active pharmaceutical ingredients known as cannabidiol, which is currently under research for treating epilepsy, pain, arthritis, schizophrenia, and other indications. Botanix is preparing for its first human trials using synthetic cannabidiol in a patented drug delivery system (Permetrex™) to directly deliver treatments to the skin.